Biogen Inc.
Link ID 246391
Title Biogen Inc.
Url http://www.biogen.com/
Description Established manufacturer of drug for treatment of multiple sclerosis, with research focusing on respiratory diseases and congestive heart failure. Offices throughout Europe, Canada with headquarters in Cambridge, Massachusetts.
Category Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Manufacturing
Keywords
Date Jul 19, 2006
Contact Name
Email
Add to My Favorite   Refer it to Friend   Report Broken Link  


 Other links at Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Manufacturing
1. NPS Pharmaceuticals, Inc.
  Discovers and develops drugs targeting skeletal, endocrinological, gastrointestinal, and central nervous system. Includes glossary, stages in pipeline, careers in North America, and investment in Salt Lake City, Utah. (Nasdaq: NPSP).
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Manufacturing


2. Ligand Pharmaceuticals Inc.
  Company developing small-molecule drugs and recombinant DNA proteins, which regulate gene activity and genetic processes in cancer and other diseases. Includes product information for patients and professionals from San Diego, California. (Nasdaq: LGND)
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Manufacturing


3. Pharming
  Offers novel platforms for the production of protein therapeutics, as well as technology and processes for the purification and formulation. Includes preclinical status of products, and details of corporation in Leiden, The Netherlands.
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Manufacturing


4. Human Genome Sciences, Inc.
  Researches and develops proprietary pharmaceutical and diagnostic products based on genes and antibodies. Offers production facilities for therapeutic proteins, and other partnerships in Rockville, Maryland. (Nasdaq: HGSI)
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Manufacturing


5. Repligen Corporation
  Researches, develops, manufactures and markets synthetic version of protein A for monoclonal antibody processing, and peptides such as secretin for gastrointestinal and pediatric neurology. Details for investors and clinical programs run from Waltham Massachusetts. (Nasdaq: RGEN)
Category:   Biotechnology and Pharmaceuticals > Pharmaceuticals > Biopharmaceuticals > Manufacturing




Home      New Listings      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing     Disclaimer
Copyright © internet-directory.com 1999-2023

Sponsors